Dr. Karin M. Reinisch's lab at Yale University focuses on the molecular mechanisms behind how cells maintain and expand their membrane structures. The research emphasizes understanding how proteins facilitate the transfer of lipids between cellular organelles, a critical process for both cell function and the formation of new organelles, which has implications for understanding neurodegenerative diseases like Alzheimer's and Parkinson's.

Dr. Martin M. Matzuk's lab at Baylor College of Medicine focuses on innovative areas of reproductive biology, particularly in developing new male contraceptives and therapeutic options for conditions like endometriosis. The lab uses advanced drug discovery techniques to target specific proteins called kinases, which play crucial roles in fertility and reproductive health. By exploring these biological processes, the lab aims to create effective non-hormonal contraceptives and medications that improve women's health outcomes, especially for those suffering from endometriosis.

Dr. Warren Ladiges' lab focuses on understanding how physical resilience impacts healthy aging. By studying how different stressors, like lack of sleep or injury, affect the body, the lab aims to identify factors that help maintain function as individuals age. The research involves using mouse models to explore physiological and molecular responses to stress, which could lead to new therapies enhancing healthy aging in people.

Jie Wu's lab at the University of Oklahoma focuses on developing new drugs that target the RET oncogene in cancers such as lung and thyroid cancer. The lab aims to create next-generation RET inhibitors that can effectively treat patients who have developed resistance to existing therapies. By optimizing novel compounds, they work towards providing better therapeutic options for patients with RET-positive tumors.

Dr. Brian A Link's lab at the Medical College of Wisconsin focuses on the cellular mechanisms involved in retinal health, particularly related to Usher syndrome type 1B. The lab investigates the MYO7A gene and its variants, which are linked to progressive retinal degeneration and other sensory deficits. By using various models including zebrafish and mutant mice, the research aims to understand how MYO7A mutations affect cell junctions in the retina, with the goal of informing future gene therapies.

Dr. Wei Wei's lab at the University of Chicago focuses on understanding how neurons in the retina, specifically starburst amacrine cells, process visual motion signals. By examining the dynamic interactions between a neuron’s physical structure and its input from other neurons, the lab aims to uncover principles of how motion detection happens at a cellular level. This research has implications for understanding normal vision and could help in treating visual disorders.

Dr. Jessica Spinelli's lab focuses on understanding how a novel metabolite named rhodoquinone (RQ) affects mitochondrial function in the context of obesity. This research investigates how RQ can potentially enhance lipid accumulation and improve energy metabolism in fat cells, which could lead to new treatments for obesity-related diseases. The lab aims to uncover the mechanisms by which RQ influences biological processes and assess its therapeutic potential for metabolic dysfunctions associated with obesity.

Dr. Susan Pereira Ribeiro's lab at Emory University focuses on understanding how immune system alterations contribute to HIV persistence, especially in individuals who use methamphetamine. The lab investigates specific molecular pathways that lead to immune dysfunction and viral reservoirs in HIV-infected individuals on antiretroviral therapy (ART). By studying these mechanisms, the lab aims to identify potential therapeutic targets to improve clinical outcomes for people living with HIV.

Dr. Riccomagno's lab focuses on understanding how neurons in the developing brain establish their connections, which is critical for learning and memory. They study specific proteins called Cas adaptor proteins that help neurons respond to various signals during their development. The goal is to reveal how these proteins coordinate different types of signals to guide the growth of axons in the brain, and how disruptions in this process can lead to neurodevelopmental disorders.

Dr. Joel D Richter's lab focuses on understanding how RNA controls neural functions that are essential for learning and memory. They study how errors in RNA translation can lead to disorders like Fragile X Syndrome and autism. The lab combines molecular biology techniques with mouse models to explore how specific proteins regulate the translation and splicing of RNA in the brain, influencing cognitive abilities and behavior.

David S. Rickman's lab focuses on understanding how prostate cancer evolves from a treatable form into a more aggressive type known as neuroendocrine prostate cancer (NEPC). They investigate the role of specific genes and epigenetic changes during this transformation, aiming to identify new treatments that can prevent or reverse this aggressive evolution. The lab uses patient-derived organoids and genetically engineered mouse models to explore these mechanisms and develop targeted therapies.

Dr. Isidore Rigoutsos' lab at Thomas Jefferson University focuses on understanding small RNA molecules, particularly variations of microRNAs, and fragments from tRNAs and rRNAs. They aim to develop specialized tools and databases that will help researchers accurately analyze and mine these RNA types from sequencing data. The lab’s work is crucial for improving our understanding of how these molecules regulate gene expression in different contexts, such as in human health and disease, particularly by investigating their roles in breast cancer metastasis.

Dr. Ramesh Rijal's lab at the University of Southern Mississippi focuses on understanding how the bacterium Mycobacterium tuberculosis survives antibiotic treatment. His research specifically investigates a molecule called extracellular polyphosphate, which Mtb uses to help tolerate stress from antibiotics. By exploring the metabolic pathways involved, the lab aims to find new strategies to make these drug-resistant bacteria more susceptible to treatment.

Dr. Benjamin Wolozin's lab at Boston University Medical Campus focuses on understanding the role of RNA modifications in Alzheimer's disease and related neurodegenerative disorders. They study how changes in specific RNA molecules can contribute to disease progression and aim to identify novel therapeutic targets that could potentially delay or alter the course of Alzheimer's. Through various experimental approaches, the lab investigates the interplay between RNA biology and the pathophysiological processes underlying neurodegeneration.

Professor Alain T Laederach's lab focuses on understanding how changes in RNA structure can affect gene expression, particularly in the context of chronic obstructive pulmonary disease (COPD). The research explores the influence of non-coding RNA regions on gene regulation and aims to uncover new targets for RNA-based therapies. By integrating advanced RNA probing technologies and transcriptomics, the lab seeks to shed light on the complexities of RNA structure and its role in disease.

Douglas N Robinson's lab at Johns Hopkins University investigates how cells respond to mechanical forces through their cytoskeletal structures. By studying how cells sense and adapt to their physical environment, the lab aims to uncover the mechanisms behind cellular processes like division and movement, which are fundamental for development and health. The research leverages unique model organisms, advanced imaging techniques, and innovative computational models to explore these fascinating interactions.

Dr. Phyllis R. Robinson's lab at the University of Maryland Baltimore County studies how light affects our physiology and behavior. They focus on a unique type of retinal cells called intrinsically photosensitive retinal ganglion cells (ipRGCs), which play an essential role in regulating our sleep patterns, mood, memory, and learning. The lab aims to uncover the complex ways these cells respond to light and how this signaling is influenced by dopamine, a vital neurochemical in our brain.

Dr. Matthew Rodeheffer's lab at Yale University focuses on understanding the mechanisms behind obesity and its related diseases. The research particularly explores how the communication between endothelial cells and fat cells contributes to the accumulation and function of fat tissue. By studying hormones like estrogen and glucocorticoids in this context, the lab aims to develop new therapeutic strategies to combat obesity and associated metabolic disorders.

Dr. Jeroen Roose's lab at UCSF focuses on understanding how T cell receptors (TCR) signal within the immune system. They study the unique mechanisms by which T cells can differentiate between self and non-self, ensuring appropriate immune responses. The lab employs a range of techniques from structural biology to computational biology to explore how TCR signaling pathways are organized and regulated.

The lab of Callum F. Ross at the University of Chicago investigates how the brain controls the movements of the tongue, which is crucial for eating and speaking. They study the biomechanics of tongue movement by analyzing muscle and brain activity during various feeding behaviors. This research aims to improve rehabilitation methods for individuals who have lost normal tongue function due to diseases or surgeries.